The opportunities of AI in healthcare
Talking Medicines co-founder Scott Crae was invited by the Ethical Medicines Industry Group (EMIG) to present on the opportunities for AI tools in a data-driven healthcare environment. EMIG is a
Talking Medicines co-founder Scott Crae was invited by the Ethical Medicines Industry Group (EMIG) to present on the opportunities for AI tools in a data-driven healthcare environment. EMIG is a
Privileged Access Management (PAM) is fundamental to cybersecurity strategies, monitoring and protecting privileged accounts that have the authority to make significant changes within IT environments. It plays a crucial role
The Internet of Things (IoT) excites many due to its potential to surface critical information swiftly, bypassing the delays of human intervention. By leveraging real-time data, businesses can achieve efficiencies,
The convergence of Immersive Virtual Reality (VR) and Artificial Intelligence (AI) is transforming medical training, offering personalised learning experiences, enhancing engagement, and empowering educators with real-time insights. Despite the challenges
In today’s security landscape, the assumption of trust is no longer viable, necessitating a stringent approach to network protection. IAM Zero Trust embodies this by enforcing the principle of ‘never
The Internet of Things (IoT) is expanding rapidly, with an ever-increasing number of devices and use cases marking the advent of a new era in connectivity. Advances in artificial intelligence
FundamentalVR, a global leader in immersive surgical training, has made significant advancements in its Fundamental Surgery platform by integrating cutting-edge artificial intelligence (AI) capabilities. These enhancements aim to drive predictive
Safeguarding your business’s digital assets while providing appropriate access levels is crucial. Identity and Access Management (IAM) policies play a vital role in organisational security, ensuring that only authorised individuals
In the dynamic landscape of healthcare, the continuous evolution of drug development and patient engagement necessitates ongoing innovation. Recently, GLP-1 drugs have garnered considerable attention for their revolutionary impact on
Identity Access Management (IAM) solutions play a critical role in minimising cyber and data governance risks by tracking and restricting access to digital systems. Fundamentally, IAM solutions capture and log